Celldex Therapeutics (CLDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-1990 | 12-1989 | 12-1988 | 12-1987 | 12-1986 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 9,321 | 6,708 | 10,211 | 11,962 | 13,098 |
| Receivables | 758 | 1,206 | 374 | 255 | 37 |
| Inventories | 368 | 322 | 120 | 69 | 32 |
| Other current assets | 341 | 426 | 279 | 312 | 117 |
| TOTAL | $10,788 | $8,663 | $10,984 | $12,598 | $13,284 |
| Non-Current Assets | |||||
| PPE Net | 2,066 | 2,098 | 900 | 755 | 498 |
| Other Non-Current Assets | 649 | 451 | 458 | 48 | 24 |
| TOTAL | $2,715 | $2,549 | $1,358 | $803 | $522 |
| Total Assets | $13,504 | $11,211 | $12,342 | $13,401 | $13,806 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 422 | 461 | 235 | 65 | 92 |
| Accrued Expenses | 1,245 | 980 | 926 | 497 | 223 |
| Other current liabilities | 400 | 394 | 128 | 520 | 160 |
| TOTAL | $2,067 | $1,835 | $1,289 | $1,082 | $475 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $2,067 | $1,835 | $1,289 | $1,082 | $475 |
| Shareholders' Equity | |||||
| Common Shares | 10 | 8 | 8 | 8 | 8 |
| Retained earnings | -8,712 | -7,293 | -5,605 | -4,337 | -3,308 |
| Other shareholders' equity | 521 | 2,279 | 2,327 | 2,466 | 2,467 |
| TOTAL | $11,436 | $9,376 | $11,053 | $12,319 | $13,331 |
| Total Liabilities And Equity | $13,503 | $11,211 | $12,342 | $13,401 | $13,806 |